The Chicago Journal

Evinature’s Clinic Support Introduces A New Era of IBD Patient Care

The treatment of gastrointestinal disorders is far from one-size-fits-all. Each patient’s needs vary, and what works for one may not work for another. This is where tailored supplement protocols come into play. By conducting assessments to understand each patient’s unique condition, dietary habits, and lifestyle, healthcare professionals can craft a customized regimen of nutraceuticals that addresses the specific needs of the individual.

While personalized IBD supplement protocols have been game-changing, it’s essential to recognize that conducting follow-ups and making regular dose adjustments are equally crucial aspects of patient care. Historically, there was no well-defined framework for optimizing patient support for tailored nutraceuticals for medical conditions.

To fill this void, leading healthcare startup Evinature launched Clinic Support, a pioneering Customer Success model that provides not only customer service, but also comprehensive patient care, including check-ins, follow-ups, adjustments, personal support, and patient/product education.

Evinature’s Clinic Support Introduces A New Era of IBD Patient Care

Photo Credit: Evinature

The Extra Mile That IBD Patients Deserve

It’s not enough to create a tailored IBD protocol and leave it at that. The human body is a dynamic system, and patients’ responses to supplements can change over time. Before Clinic Support, there existed a significant deficiency in IBD customer success where patients frequently had to resort to conducting their own research, which often resulted in misinformation and confusion.

The team behind Evinature is dedicated to more than just providing supplements. They recognize every IBD patient’s need for emotional support and a credible source of medical information, leading to the inception of Clinic Support. “Unfortunately the medical system is overburdened, so often patients will go online to seek information which may not be from a professional source,” says Nir Salomon, Co-Founder and Head of R&D at Evinuature. “Online groups and forums offer a lot of important resources, but these patients require solid, easily accessible medical advice. We also understand that taking a natural compound for IBD is a brave step, and the extra emotional support can make all the difference to treatment adherence.”

Moreover, Shirli Taher-Lev, Head of Customer Success at Evinature, shares why Clinic Support is revolutionary in IBD patient care: “We care. Above all else, patient well-being is everything. Whether they need personal adjustments, information on their condition, or simply emotional support for what they’re going through, we make a concerted effort to give as much time and energy as possible. But more than that, we actively initiate conversation with our clients – we’re not waiting for them to tell us how they feel, we actively approach them for regular follow-ups. This helps us rule out any contraindications or bad reactions so we can make adjustments and offer the best care possible throughout their recovery. And you can see it makes a difference to our patients, they’re so thankful for the time and attention.” 

Patient Responses

Clinic Support’s impact on IBD patients has been overwhelmingly positive, as evidenced by the outpouring of messages from individuals who have experienced the benefits of unwavering, hands-on support. 

Here are some of the patient’s testimonials via Trustpilot:

“Evinature has dedicated professionals who reached out to us by phone and discussed my daughter’s needs. I could not believe the personalized care and they truly value their customers.” 

– Mr. Gonzalez 

“I am so thankful for the care I’ve received and the staff on hand to help answer any questions I’ve had. I will definitely continue my maintenance protocol to ensure I stay healthy for when baby arrives! Thank you to all who have helped me on this journey.”

– Alexa Taylor 

“I love the ongoing support I get from the Evinature team and how easy it is to reorder! I’m extremely grateful for Evinature and for the chance to get my “normal” life back!”

– Heather Odom 

“I never expected such a personalized experience. Nir emailed me asking if we could talk on the phone and was so helpful. He continues to walk me through this process and I am so grateful for his calm and encouraging demeanor. Highly recommend!!”

– Robin Schwarz 

Scoliosis: what is it and how can you treat it?

Scoliosis Scoliosis is a condition in which the spine bends abnormally sideways, forming a C or S shape.

It can occur in children, adolescents, or adults and can be congenital, idiopathic (for unknown reasons), or associated with other diseases or injuries.

Symptoms might range from misplaced shoulders or hips to back pain and visible deformity.

A physical examination and imaging studies are utilized to make a diagnosis.

Treatment methods may include monitoring, bracing, physical therapy, exercise, pain management, or surgery, depending on the severity.

Early detection and treatment are crucial for successful scoliosis management.

How to identify scoliosis

Scoliosis can be identified by uneven shoulders or hips, asymmetry of the back, apparent deformity, or bending to one side.

As a result of the incorrect curvature of the spine, a person may have back pain or muscle imbalances.

Assume you or someone you know is experiencing any of the following symptoms.

In this case, it is vital to get medical attention from a healthcare professional who can do a physical exam and order imaging tests to confirm the diagnosis.

Controlling scoliosis and preventing consequences requires early detection and treatment.

Dangers of scoliosis

Scoliosis is not necessarily deadly, but it can have a significant impact on a person’s quality of life.

In severe situations, scoliosis can cause pain, discomfort, and deformity, leading to mental anguish, self-consciousness, and a reduced capacity to participate in physical activities.

Awkward spine curvature can also impede lung function and cause breathing issues, especially if it involves the ribs.

Furthermore, if left untreated, scoliosis can develop and expand, increasing the risk of complications.

In severe circumstances, scoliosis can induce spinal cord compression, nerve damage, and even paralysis.

As a result, early detection and treatment are crucial for avoiding development and controlling symptoms successfully.

Children and teenagers are especially vulnerable to the negative effects of scoliosis because abnormal curvature can hinder growth and development.

As a result, it is vital that parents, teachers, and healthcare professionals understand the signs and symptoms of scoliosis and seek quick medical attention if they suspect their child is suffering from it.

Read also: Uber Promotes Safe E-biking with New Trade-in Program

Letting it run undiagnosed

Scoliosis can progress and become more severe over time if left untreated.

This can result in a variety of unfavorable outcomes, including increased pain and discomfort, reduced mobility, and visible deformity.

In severe situations, scoliosis can cause spinal cord or nerve root compression, resulting in neurological symptoms such as numbness, tingling, or paralysis in the arms or legs.

Scoliosis can also impact lung function, resulting in breathing problems and decreased exercise capacity.

Misdiagnosed and untreated scoliosis can result in mental distress and a reduced quality of life over time.

As a result, it is vital to get medical attention if you suspect you or someone you know has scoliosis.

What to do when it gets bad

If you are experiencing significant discomfort as a consequence of undiscovered scoliosis, it is vital that you get medical attention from a healthcare professional as soon as possible.

Pain management approaches include over-the-counter pain relievers, physical therapy, and other conservative therapies for discomfort.

Rest, avoiding aggravating activities, and maintaining appropriate posture may all be useful.

However, it is vital to address the underlying cause of the pain by acquiring an accurate diagnosis and developing a treatment plan tailored to your specific condition.

Delaying therapy for scoliosis can result in increased discomfort and serious difficulties, therefore it is vital to get medical help as soon as possible to address the pain and manage the condition effectively.


Treatment techniques for scoliosis vary based on the degree of curvature and may include:

  • Monitoring
  • Bracing
  • Physical therapy
  • Exercise
  • Pain management
  • Surgery

If scoliosis is detected early, conservative therapies such as physical therapy and bracing may prevent further curvature progression.

Physical therapy can help you improve your posture, increase your flexibility, and strengthen the muscles that support your spine.

Bracing can also help to stop further progression in some cases, especially in children and adolescents who are still growing.

While conservative treatments are usually used to treat scoliosis, surgery may be necessary in severe cases to correct the curvature and stabilize the spine.

Early detection and treatment are crucial for effectively treating scoliosis and preventing potential complications.

Estrogen has potential to go lower, according to studies

EstrogenEstrogen is a female hormone that is produced mostly in the ovaries and is necessary for the creation and function of reproductive organs.

It regulates menstruation, encourages endometrial growth, and is in charge of the development of female secondary sex characteristics.

Estrogen is combined with other hormones in birth control pills to prevent pregnancy.

It suppresses ovulation and thickens cervical mucus, making sperm more difficult to reach an egg.

Estrogen also aids in the control of the menstrual cycle, decreases the risk of ovarian and endometrial cancer, and may provide other health benefits such as acne reduction and bone density enhancement.

Side effects

The inclusion of estrogen in birth control pills raises the risk of blood clots and stroke, especially in women who smoke or have other cardiovascular risk factors.

Although estrogen may increase the chance of developing breast cancer, the absolute risk is low.

Nausea and breast soreness are the minor estrogen side effects of birth control pills.

These negative effects are usually transitory and disappear within a few weeks.

Headaches, mood changes, and libido variations are among the other minor adverse effects.

The benefits of estrogen-containing birth control pills outweigh the risks for the vast majority of women, but any concerns or potential adverse effects should be explored with a healthcare provider.

New findings

There is ongoing research to create birth control that is both effective and low in estrogen.

Researchers revealed, using a mathematical model, that decreasing the estrogen level in traditional contraceptives by 92% still has the power to prevent pregnancy.

The research was published in the April 13 edition of PLOS Computational Biology.

They claimed that a low dose of progesterone, another contraceptive hormone, or a combination of the two hormones might prevent ovulation.

However, the drugs would have to be given at a critical point in the menstrual cycle.

Many highly successful contraceptives include enough estrogen to render them useless for some people, particularly those with a family history of hypertension or breast cancer.

Furthermore, establishing in clinical trials that lower doses of the hormones prevent ovulation may enable individuals at high risk of severe side effects with access to estrogen-based contraception.

Read also: Abortion drug advocated for restrictions

The mathematical model

Brenda Lyn Gavina and Aurelio de los Reyes of the University of the Philippines Diliman in the Philippines expanded on an existing menstrual cycle mathematical model.

They looked at real-world data from 23 women ages 20 to 34.

The model takes into account the intricacies of blood hormone levels from three major sources:

  • The pituitary glands
  • The ovaries
  • Hormonal birth control

Throughout a menstrual cycle, the researchers duplicated progesterone or estrogen levels that inhibited ovulation.

They used the same dose levels as standard methods of birth control.

The researchers then utilized optimum control theory, a mathematical approach, to determine the least amount of estrogen or progesterone that may prevent ovulation.

They observed that administering 8% estrogen 11 days after the start of the menstrual cycle inhibited the ovary from producing an egg.

Gavina and de los Reyes also observed that utilizing less estrogen and progesterone during that time period caused ovulation to be disturbed.

According to the researchers, the dose might be delivered by injections or implants.

“We did not only lower the dosage, but we also identified when to administer the contraceptive,” said de los Reyes.

According to Alison Edelman, a gynecologist at Oregon Health & Science University in Portland, a modest amount of estrogen would probably ease some of the negative effects.

The new discoveries, according to Edelman, will not be utilized to produce better contraception anytime soon.

The model assumes that estrogen from birth control remains constant throughout time and does not take into account how the hormone is absorbed by the body.

It is likely to change, impacting the medicine’s effectiveness.

“I want to assure people that [low-dose estrogen in birth control] is already being looked at,” said Edelman.

She emphasized that people may now use hormone-based birth control that is both safe and effective.

Gavina and de los Reyes expressed a wish to cooperate with doctors like Edelman to make their models more relevant to researchers working on low-dose birth control medicines.

Cancer in mice was reduced 90% with battery study

Cancer — A person’s presence can drain a room’s energy in a number of ways.

A person who is always negative, criticizing, or moaning, for example, may have a bad impact on the attitude and morale of others around them.

Someone who is really apprehensive or stressed out may emanate a tight or unpleasant energy that affects others.

Furthermore, a person who dominates conversations or takes up a lot of physical space in a room may produce discomfort or suffocation for others in the room..

These are only a few examples of how a person’s demeanor or behavior may alter the ambiance in a room, and it is vital to be aware of how our actions influence others around us.

While this may be distressing for people, it is considered a fantastic idea if a battery can do the same for a tumor.

Batteries and tumors

A mouse study discovered that encircling a tumor with a tiny self-charging battery can take oxygen from the cancer cell’s surrounding, enhancing the efficiency of cancer therapy.

In the March 31 issue of Science Advances, researchers reported that mice had small batteries wrapped around their breast cancer tumors.

In two weeks, when combined with cancer therapy, the tumor volume decreased by 90%.

Solid tumors, such as breast cancer, commonly expand, growing faster than the blood supply can keep up with.

Many tumors’ cores may be hypoxic, with lower oxygen levels than the surrounding tissue, due to growth.


Yongyao Xia, a materials scientist at Fudan University in Shanghai who specializes in battery materials, said:

“Hypoxia is a double-edged sword.”

Low oxygen levels in tumors indicate that the body’s immune cells are unable to survive long enough to eliminate the malignant cells.

Furthermore, Fan Zhang, a biomedical materials researcher at Fudan University, noted that hypoxic cells resist radiation and traditional chemotherapies due to insufficient blood flow to provide a deadly dose.

Xia and Zhang assert in a new study:

“On the other hand, it provides a target for precision treatment of tumors.”


Hypoxia may operate as a signaling molecule for compounds known as hypoxia-activated prodrugs.

According to Qin Zhang, a molecular biologist at the University of Texas Southwestern Medical Center in Dallas, chemotherapeutic drugs are linked to a linking molecule that ensures the treatment is only active in low-oxygen settings.

Clinical trials of hypoxia-activated prodrugs, on the other hand, demonstrated no benefits.

The researchers believe this is because the solid tumors against which they were deployed were either not hypoxic or were not hypoxic enough.

Xia and Fan Zhang sought to find a way to make tumors more hypoxic so that prodrugs had a better chance of functioning.

Read also: Insomnia linked to heart attacks in new studies

The batteries

The researchers and their colleagues employed a tiny, flexible battery that could partially wrap around a tumor.

It charges itself with a zinc electrode by drawing oxygen from its environment, resulting in very reactive oxygen pairs that might damage DNA.

However, they are not a viable supply of oxygen for cells.

The tumors in the mice decreased by roughly 26% of their original size two weeks after the battery was implanted.

It may accomplish this by absorbing the vast majority of available oxygen and producing a significant number of reactive oxygen pairs.

Shrinking the tumor

When combined with a hypoxia-activated prodrug, the average tumor size was decreased by 90%.

“I think the concept, the scientific basis, is solid,” said Qin Zhang.

He also remarked that, while the findings are encouraging, they are still in their early stages.

The batteries were only used on mice and only against mouse-specific breast cancer.

“It has to be tested in several breast cancer models and also has to be tested in other cancer models,” Zhang said, referring to humans.

He also claimed that a 90% reduction in tumor size is not the same as a 100% reduction.

“There’s still 10 percent left,” he said.

If the cells survive, it might mean they are resistant to hypoxia, allowing the tumor to develop again.

Zhang added that, like many other therapies, it would need to be combined with others to ensure total tumor eradication.

Xia, Fan Zhang, and his colleagues are thinking about ways to make the battery more flexible and powerful for human-sized tumors, using battery energy to suck air and starve cancer.

The Watershed Moment of Cybin’s Purchase of Small Pharma Inc.: Reinventing the Future of Mental Health Treatment

As we chronicle the evolution of mental healthcare, we cannot overlook the seismic impact of psychedelic medicine. Leading the charge in this transformative journey is Cybin(NEO:CYBN NYSE American:CYBN), a company that has now strategically positioned itself as a vanguard in the sector with its recent acquisition of Small Pharma. This merger ushers in an era where mental health conditions are met with cutting-edge, research-based therapeutic solutions.

The Rise of Cybin in the World of Psychedelic Treatments

Cybin’s mission has been unambiguous from the get-go: to revolutionize mental health treatment. Its relentless focus has been on developing unique pharmaceutical platforms, avant-garde drug delivery technologies, and treatment strategies tailored for diverse mental health issues. Supported by a robust network of experts and partners, Cybin’s dedication to shaping the mental health sector of tomorrow is abundantly clear.

The Strategic Symbiosis with Small Pharma

The acquisition of Small Pharma isn’t just a business move for Cybin; it’s a fusion of like-minded innovation and specialized know-how. This merger enriches Cybin’s intellectual property portfolio, which now boasts 28 granted patents and a further 159 under review. Importantly, it provides Cybin with unparalleled access to comprehensive data on DMT (Dimethyltryptamine) and dDMT, enriching their already extensive research in the field of psychedelic substances.

Additionally, Small Pharma contributes two proprietary, advanced clinical trials focused on treating depression and anxiety disorders. Having proven their safety and effectiveness, these programs represent a transformative leap in mental healthcare. The collaboration between these two titans will optimize key resources, including manpower, capabilities, and intellectual assets.

What Lies Ahead for Cybin and Small Pharma

As Cybin prepares for the Phase 3 trials of CYB003 in early 2024, its path will be closely scrutinized by industry observers, investors, and enthusiasts. The merger fortifies Cybin’s stronghold in the world of psychedelic medicine by solidifying its intellectual holdings.

The amalgamation of the research and development initiatives from both companies opens a treasure chest of new prospects, enhancing operational efficacy and cost management. Notably, the partnership heralds an unmatched compendium of research data on DMT and dDMT, making the joined entity a global leader in the study of these psychoactive molecules.

Under the leadership of Doug Drysdale, Cybin’s CEO with three decades of healthcare experience, the combined talents of both firms will synergize to accelerate the R&D and clinical applications of their collective portfolios.

According to Drysdale, this merger does more than create an industry trailblazer in groundbreaking psychedelic treatments. It amplifies the joint expertise of Cybin and Small Pharma in the pursuit of developing state-of-the-art deuterated tryptamine-based therapies.

A Bright Horizon for Mental Healthcare

At the core of this merger is a renewed sense of optimism for those struggling with mental health issues. As two industry frontrunners unify, the scope for innovation becomes boundless. This union is not just a business arrangement; it’s a powerful affirmation of a shared vision to revolutionize the mental health sector. The future looks promising, and with the combined capabilities of Cybin and Small Pharma, it’s clear who will be lighting the way.

Dr. Venus Nicolino Stresses That Alzheimer’s Disease and Other Dementias Are Personal and Public Health Challenges

Los Angeles Times bestselling author Dr. Venus Nicolino sees the toll dementia takes on patients and loved ones. The numbers are staggering. In the U.S., 1 in 3 seniors dies with Alzheimer’s or another dementia. Alzheimer’s disease kills more than breast cancer and prostate cancer combined. More than 6 million people in the United States have Alzheimer’s. 

A doctor of clinical psychology, Nicolino views Alzheimer’s disease and other dementias as major public health issues with far-reaching implications. 

“They pose significant challenges for individuals, families, health care systems, and society as a whole,” she says. “The prevalence of dementia increases with age, and as life expectancy rises, the impact of these diseases becomes even more significant.”

Alzheimer’s disease is the most common form of dementia, accounting for about 60% to 70% of cases. Other types of dementia include vascular dementia, Lewy body dementia, frontotemporal dementia, and mixed dementia. 

“Globally, an estimated 50 million people are living with dementia,” Nicolino says. “This number is projected to triple by 2050.”

Dr. Venus Nicolino Understands That Alzheimer’s Disease Is Notoriously Difficult — and Expensive — To Treat

Despite extensive research, there’s no cure for Alzheimer’s or other dementias. Medication can ease symptoms, but they don’t stop or reverse the disease’s progression. 

Nicolino supports efforts to understand the underlying causes, risk factors, and mechanisms of dementia and Alzheimer’s. She’s hopeful about research into early detection and intervention strategies. Such medical breakthroughs can enhance the quality of life for patients. 

Until science makes a breakthrough, dementia will continue to place a tremendous burden on health care systems, Nicolino explains. 

“The complex nature of these diseases requires comprehensive medical, social, and long-term care services,” she says. “The cost of dementia care is substantial, including diagnosis, treatment, and caregiving expenses. Moreover, the progressive nature of dementia often necessitates long-term care and support, which can strain health care systems.”

How Dementia Affects Caregivers

Alzheimer’s and other dementias affect the individuals diagnosed, their families, and their caregivers. Few experiences are worse than witnessing a loved one’s cognitive decline and personality changes. Such challenging responsibilities can increase stress, anxiety, and depression in the caregivers. 

“Caregivers often face physical, emotional, and financial strains,” says Dr. Venus Nicolino. “Dementia care requires constant supervision, assistance with daily activities, and significant time commitments.”

Another problem nags at the families of Alzheimer’s or dementia patients: The economic impact is substantial. Medical expenses, hospitalizations, and long-term care for the direct costs are considerable. But indirect costs also factor into the price tag; for example, caregivers may quit their jobs to provide care for a loved one.

Of the many health conditions that plague society, dementia is among the costliest to treat. In 2023, Alzheimer’s and other dementias will cost the U.S. $345 billion. That figure doesn’t include the financial value of unpaid caregiving.

Still, there are things that caregivers can do to ease the strain of disease progression, tips Dr. Nicolino.

“Engage individuals in activities that stimulate their cognitive abilities and provide a sense of accomplishment,” she says. “This can include puzzles, memory games, music therapy, and art therapy. Stimulating the mind can help maintain cognitive function, boost mood, and provide a sense of purpose.”

Dr. Venus Nicolino Thinks the U.S. Should Take a Multifaceted Approach to Addressing Alzheimer’s

“Public health initiatives should focus on risk reduction strategies, such as promoting a healthy lifestyle, cardiovascular health, and lifelong learning,” Nicolino says. “Addressing these issues requires a comprehensive approach.”

Public health interventions include raising disease awareness, promoting early diagnosis, implementing supportive policies, and investing in research. Such programs can involve research, health care services, public awareness, and policies prioritizing prevention, diagnosis, and support for affected individuals and their caregivers.

“Furthermore,” Nicolino adds, “it is essential to ease the burden on caregivers by supporting them with respite care, education, and financial assistance.” 

Advice on Helping Individuals With Alzheimer’s Disease and Dementia

In her work in clinical psychology, Dr. Venus Nicolino has learned how to help individuals with Alzheimer’s disease and dementia and their family members. Through therapy, they can experience less anxiety, sadness, and depression about their diagnosis. 

“Helping individuals with Alzheimer’s disease and dementia, as well as their family members, cope with anxiety, sadness, and depression about the diagnosis requires a multidimensional approach,” she says. “This approach combines emotional support, education, and practical strategies.” 

 Dr. Venus Nicolino’s tips for assisting:

  • Provide accurate and transparent information about the disease, its progression, and available treatment options. Help individuals and their families understand what to expect and how to plan for the future. 
  • Offer emotional support through counseling services or support groups specifically tailored for individuals with Alzheimer’s and their families. 
  • Professional counselors or therapists can provide individual or family therapy to address specific emotional concerns.

“Supporting family caregivers is crucial since they often experience high levels of stress, burnout, and emotional strain,” Nicolino says. “Provide information on available caregiver support programs, respite care services, and counseling to help them cope with their emotions and develop effective coping mechanisms.”

120/Life: A Revolutionary Approach to Cardiovascular Health

High blood pressure is a problem that haunts many, including athletes and individuals leading active lifestyles. Left unchecked, it can lead to serious heart conditions. Within the United States alone, an estimated 108 million people suffer from this condition. Among them was Ira Antelis, whose personal struggle with high blood pressure led him to join forces with his lifelong friend and nutritionist, Susan Schachter, to launch 120/Life, a game-changing company with a mission to promote cardiovascular health through natural and effective solutions.

120/Life was founded on the belief that controlling blood pressure doesn’t have to be a complex task. The concept was born when Ira was diagnosed with high blood pressure and faced the terrifying prospect of surgery. In a desperate bid to lower his blood pressure, Ira changed his diet, began exercising, and started researching natural remedies. He discovered powerful biochemistry in common produce, and with Susan’s help, blended a juice that lowered his BP by 30 points in two weeks. This incredible result led to the birth of 120/Life, the functional beverage that promises support for healthier blood pressure levels in as little as two weeks.

120/Life offers a natural and functional beverage created from a blend of potent natural ingredients like beetroot, hibiscus, and pomegranate. Available as ready-to-drink juice and convenient powdered drink mix, 120/Life provides a wholesome approach to improved well-being. The success of this product is attested by health professionals such as Dr. Lowell Steen, M.D., who lauds its ability to drastically reduce blood pressure, and Dr. Nimit Aggarwal, M.D., who regards it as an amazing addition to the toolkit for managing patients with high blood pressure.

120/Life is committed to empowering individuals with education and tools to manage their blood pressure. They provide resources ranging from a free ebook on BP, a free custom app called BPWise to track numbers, news, tips, clinical studies, videos, and of course, the juice that started it all. The company prides itself on its incredible customer service, with Ira himself handling all customer inquiries and typically responding within one hour.

120/Life’s approach to cardiovascular health is simple, effective, and without pressure. Through their innovative product and unwavering commitment, they are changing lives one heart at a time. 120/Life invites all to be a part of this journey towards better health. As Ira Antelis, Founder of 120/Life® puts it, “At 120/Life, we’re driven by results, not promises. Our journey is about genuine impact, one heart at a time.


Harnessing Clinical Data: The Path To Faster Drug Approvals

Clinical data is revolutionizing the healthcare industry. In an era where precision, speed, and accuracy are paramount, effectively utilizing this vast amount of information can result in groundbreaking advancements, from accelerating drug approvals to ensuring treatments are safer and more effective.

It’s essential to recognize that every data point represents a stride towards improved patient care. It’s not just about expediting processes but ensuring every approved drug meets the highest safety and efficacy standards. Keep reading for more details on harnessing clinical data for expedited drug approvals.

  1. Understanding The Power Of Clinical Data

Clinical data encompasses observations, tests, and results obtained during clinical trials and patient care. When analyzed and interpreted correctly, this data provides insights that are pivotal in shaping medical decisions. Each data point has the potential to confirm a drug’s effectiveness or unveil its side effects.

By harnessing this information, researchers and medical professionals can ascertain the safety and efficacy of treatments with a higher degree of certainty. This clarity is essential, especially when introducing new treatments to the market. Moreover, with solid clinical data at their disposal, decisions are made based on comprehensive knowledge, underscoring the unmatched value of clinical data in elevating healthcare and improving patient outcomes.

  1. Embracing Technology

With the advent of modern technology, the realm of medical research has seen a transformative shift. Leveraging Electronic Data Capture (EDC) and similar technologies has enhanced the efficiency of gathering and managing clinical trial information.

However, analyzing this data can still be labor-intensive and susceptible to mistakes. The Study Data Tabulation Model (SDTM) offers a versatile solution. Developed by the Clinical Data Interchange Standards Consortium (CDISC) and recognized by the Food and Drug Administration (FDA), SDTM mapping serves as a global standard for streamlining clinical trial information. This standardization is critical for several reasons, including:

  • Efficiency in data review: With vast data volumes, consistency is critical. A standardized format simplifies data review, making it faster and more efficient.
  • Enhanced communication: Streamlining data management ensures that all stakeholders, from researchers to regulators, are on the same page, promoting clearer communication and reducing potential misunderstandings.
  • Regulatory compliance: Since many regulatory bodies, including the FDA, now require or recommend SDTM-formatted submissions, ensuring your data aligns with these standards isn’t just good practice – it’s often mandatory.

However, transitioning to SDTM can pose challenges. It’s essential to have skilled personnel familiar with both clinical data and the intricacies of SDTM. Fortunately, these challenges can be successfully navigated with the right training and tools, paving the way for streamlined data submission and faster drug approvals.

  1. Ensuring Data Quality

Achieving top-tier data quality is fundamental in the drug approval process. Without reliable data, conclusions may be skewed, potentially jeopardizing patient safety. Consider implementing the following strategies to ensure data quality:

  • Set strict protocols for data entry: Having standardized procedures ensures uniformity and reduces the risk of discrepancies. Utilize advanced software with algorithms that instantly spot inconsistencies or outliers, facilitating timely rectifications.
  • Train your team: Continuously educate healthcare professionals about the importance of precise data reporting. Knowledge refreshers and workshops can help maintain high standards of data integrity.
  • Conduct regular data audits: Review the collected data to identify any deviations. Also, embrace feedback; if stakeholders spot any inconsistencies, address them promptly.

Adhering to these steps solidifies the integrity and reliability of your clinical data, setting the stage for accurate research findings. Besides, confidence in data quality inherently positions you to speed up drug approvals.

  1. Fostering A Culture Of Collaboration

Collaboration is the backbone of clinical research. By forging alliances and pooling resources, stakeholders can harness diverse expertise and perspectives, driving more comprehensive and robust conclusions.

Engaging with fellow researchers offers the opportunity to exchange valuable methodologies, insights, and potential challenges. Partnering with pharmaceutical companies can provide access to cutting-edge technologies and resources. And liaising with regulatory bodies guarantees that the research complies with current standards and guidelines.

This proactive engagement fosters a more comprehensive view of the drug in question and, thus, a smoother approval process.

  1. Adapting To The Evolving Nature Of Clinical Data

Clinical data isn’t static. The medical landscape constantly evolves, introducing new methodologies, techniques, and tools. Therefore, staying agile is crucial. Below are some ways to adapt to these changes:

  • Continuous training: Equip teams with the latest knowledge, aligning their expertise with modern standards.
  • Update technology platforms: Software needs regular updates to capture the richness of the evolving data.
  • Reevaluate protocols: Revisiting established protocols allows for refinement in light of new insights and ensures that data collection and analysis remain rigorous.

Fostering an adaptive mindset and being receptive to change ensures you’re gathering the most current and relevant data and leveraging it to its fullest potential, leading to better-informed decisions and more efficient drug development.


Harnessing the dynamic nature of clinical data promises transformative shifts in drug approvals. By integrating the above strategies, the medical community stands poised to usher in an era of rapid yet thorough approvals. With each step anchored in data integrity and innovation, the path forward promises swifter processes and the assurance of safer, effective treatments for patients.

Unlocking the Mysteries of the Iris: A Deep Dive with Ginger DeClue, Founder of Detox by DeClue

From ancient traditions to modern wellness routines, the eye, particularly the iris, has long been considered a doorway into our health. Ginger DeClue, the visionary behind Detox by DeClue, is shining a light on the fascinating practice of iridology and how it seamlessly aligns with holistic health and detoxification.

The Power of the Iris

Iridology, Ginger explains, is an ancient technique of interpreting the patterns and colors of the iris to understand potential weaknesses and toxic build-ups in the body. Each body part resonates with a specific section of the iris. It’s crucial to note, however, that while iridology can indicate potential health areas to address, it doesn’t diagnose illnesses.

What’s genuinely intriguing is the dynamic nature of the iris. As individuals undergo detoxification, their iris patterns and colors can actually shift and evolve, mirroring their internal cleansing process.

Unlocking the Mysteries of the Iris: A Deep Dive with Ginger DeClue, Founder of Detox by DeClue

Integrating Iridology into Detox by DeClue

But how does iridology fit into Ginger’s holistic health framework? At Detox by DeClue, an iridology report is the stepping stone to the D8 cellular reconstruction system. This consultation, which provides a comprehensive iris assessment, sets the foundation for a tailored herbal protocol. 

“The herbs,” Ginger clarifies, “augment the detoxification process. Since every individual has unique needs, these herbal protocols are personalized based on the eye readings and additional health information.”

Journey of Wisdom and Practice

Although Ginger underwent formal training, including an iridology certificate course, she emphasizes the unparalleled value of hands-on experience. Having read over 4,000 sets of eyes and taught over 3,000 students, her approach is honed by wisdom—something only continuous practice can cultivate.

Iridology’s Impact

While iridology isn’t a diagnostic tool in the conventional sense, it offers invaluable insights. By understanding weaknesses and potential toxic accumulations in the body, individuals gain a clearer picture of their health journey. Ginger’s approach reframes patients as ‘students’, empowering them with knowledge about their bodies and health choices.

The Iridology Experience

For anyone interested, Ginger breaks down the process into simple steps. Students take and submit photographs of their eyes. These photos, accompanied by their health histories, are analyzed to identify potential health challenges. The subsequent report is both insightful and transformative, often leaving students astonished by its accuracy.

Unlocking the Mysteries of the Iris: A Deep Dive with Ginger DeClue, Founder of Detox by DeClue

Interpreting the Iris

Ginger’s vast experience has equipped her with the ability to discern specific health indicators in the eyes, from potential detox pathway blockages to underlying systemic weaknesses. These interpretations, combined with Ginger’s holistic approach, offer students a comprehensive roadmap to enhanced well-being.

Memorable Cases

Ginger fondly recalls a particularly poignant case where iridology not only identified physical health issues but also emotional traumas, showcasing the profound interconnectedness of our emotional and physical states.

A Holistic Fusion

For many, iridology provides a sense of validation often missing from traditional medical practices. While Ginger’s approach doesn’t replace conventional medical treatments, it complements them, bridging the gap between holistic and mainstream medical care.

In a world constantly searching for balance, Ginger DeClue and her Detox by DeClue offer a harmonious blend of ancient wisdom and modern techniques, all viewed through the captivating lens of the iris.

The Rise of Subscription-Based Healthcare: Healthvio Takes a Leap

The realm of healthcare, often steeped in tradition and resistant to change, is at a crossroads. It’s an industry revered for its invaluable role in society. It faces mounting criticism for being a maze of high costs, enigmatic billing, and sometimes inaccessible services. Amidst these critiques, there emerges a subscription model. 

As platforms like Netflix have engrained themselves in our daily lives, providing predictable costs and vast libraries at our fingertips, one can’t help but wonder: Could a similar model bring the same convenience and transparency to the labyrinthine world of healthcare? Leading this potential paradigm shift is Healthvio, with its innovative approach. Let’s delve deeper into this evolution, analyzing its roots, potential, and the data supporting its rise.

Why the Current Model Doesn’t Hold Up

Historically, the healthcare industry has often been seen as a necessary evil. A 2019 Journal of Health Economics study stated that unexpected healthcare costs have long been a leading cause of financial distress for individuals. With nearly 40% of Americans struggling to cover a $400 emergency expense, according to the Federal Reserve, these unpredictable bills can wreak havoc on personal finances.

Enter Subscription-Based Models

Healthvio is leading the charge into the subscription model, not as a novelty but in response to an evident demand. Their Healthvio Prime Subscription offers a multi-dimensional healthcare experience, integrating medical consultations, prescription services, and wellness solutions. The objective? A predictable expense and a comprehensive healthcare experience from home.

Subscription models in other sectors have shown impressive traction. The Deloitte Global Media Consumer Survey 2020 indicated that 53% of respondents subscribed to a video streaming service. Healthvio is banking on this.

Benefits Unfolded with Data

  1. Affordability: In a study by Health System Tracker, over 29% of Americans reported difficulty paying their medical bills. Healthvio’s model promises to alleviate this strain, offering a fixed cost that can be budgeted monthly or annually.
  2. Quality Assurance: The subscription model isn’t merely about cost; it’s about the caliber of care. With the telemedicine market expected to grow at a CAGR of 15.1% from 2021 to 2028, according to Grand View Research, it’s evident that there’s trust and demand for virtual consultations.
  3. Convenience in Busy Times: In today’s fast-paced world, accessing services from home is not just a luxury but a necessity. A survey by Mordor Intelligence found that over 60% of participants favored telehealth for its convenience, saving them travel time and providing flexible consultation timings.

A Balanced Perspective

While the subscription model holds promise, it’s essential to recognize its early stages in the healthcare sector. Healthvio’s endeavors look promising, and their platform has the potential to be a trailblazer. However, the success of such models will also depend on regulatory endorsements, integration with other healthcare systems, and, most importantly, patient outcomes.

As consumers and industry experts keenly watch Healthvio’s progress, there’s no denying that the winds of change are blowing in the healthcare sector. With affordability, quality, and convenience as its pillars, Healthvio’s model might just be the disruptor the industry needs.

To follow their journey or explore their offerings, check out However, as with all emerging models, a thoughtful and informed approach to subscription-based healthcare is advisable.